Jagsonpal Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of September 2025: 49.00%

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has an Asset Resilience Ratio of 49.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs1.47 Billion

≈ $15.85 Million USD Cash + Short-term Investments

Total Assets

Rs2.99 Billion

≈ $32.34 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2025)

This chart shows how Jagsonpal Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Check Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Jagsonpal Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs1.47 Billion	49.0%
Total Liquid Assets	Rs1.47 Billion	49.00%

Asset Resilience Insights

Very High Liquidity: Jagsonpal Pharmaceuticals Limited maintains exceptional liquid asset reserves at 49.00% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Jagsonpal Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare Jagsonpal Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Jagsonpal Pharmaceuticals Limited (2017–2025)

The table below shows the annual Asset Resilience Ratio data for Jagsonpal Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	42.23%	Rs1.18 Billion ≈ $12.71 Million	Rs2.78 Billion ≈ $30.09 Million	-20.04pp
2024-03-31	62.27%	Rs1.35 Billion ≈ $14.62 Million	Rs2.17 Billion ≈ $23.48 Million	+3.31pp
2023-03-31	58.96%	Rs1.15 Billion ≈ $12.43 Million	Rs1.95 Billion ≈ $21.08 Million	+30.61pp
2022-03-31	28.35%	Rs477.64 Million ≈ $5.17 Million	Rs1.68 Billion ≈ $18.22 Million	-9.52pp
2021-03-31	37.88%	Rs621.94 Million ≈ $6.73 Million	Rs1.64 Billion ≈ $17.76 Million	+8.57pp
2020-03-31	29.30%	Rs430.64 Million ≈ $4.66 Million	Rs1.47 Billion ≈ $15.89 Million	+6.24pp
2019-03-31	23.06%	Rs313.12 Million ≈ $3.39 Million	Rs1.36 Billion ≈ $14.68 Million	+16.59pp
2018-03-31	6.47%	Rs83.98 Million ≈ $908.23K	Rs1.30 Billion ≈ $14.04 Million	-14.95pp
2017-03-31	21.42%	Rs305.53 Million ≈ $3.30 Million	Rs1.43 Billion ≈ $15.42 Million	--

pp = percentage points

About Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$170.27 Million

Rs15.74 Billion INR

Market Cap Rank

#17127 Global

#905 in India

Share Price

Rs235.37

Change (1 day)

+1.98%

52-Week Range

Rs161.07 - Rs278.35

All Time High

Rs761.20